Higher serum IL-6 levels in NSCLC patients in the current study was not correlated with miR-146a or miR-155 expression, although a positive correlation between miR-146a and IL-1β was observed especially in patients with a GG genotype. This evidence concerns the gene IL6 and non-small cell lung carcinoma.